Follow the people · Insider
Fady Ibraham Malik
Fady Ibraham Malik files insider transactions with the SEC as an evp research & development of Cytokinetics (CYTK). We hold 12 disclosed purchases and sales filed since 5 September 2012, 5 of them in the last 90 days.
- Files forCYTK
- Disclosed buys and sells12 in all, 5 in the last 90 days
- Last disclosure8 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 4 September 2012 — 8 September 2026EVP Research & Development · Cytokinetics (CYTK)388 Form 4 lines · source: SEC Form 4
- Filed 10 March 2022 — 18 June 2026Director · Rocket Pharmaceuticals (RCKT)8 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 3,500 shares of CytokineticsSEC Form 48 September 2026Common Stock · traded 8 September 2026 · filed 8 September 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 48 September 2026Common Stock · traded 8 September 2026 · filed 8 September 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 48 September 2026Non-Qualified Stock Option (Right to Buy) · traded 8 September 2026 · filed 8 September 2026
- exercised options over 3,500 shares of CytokineticsSEC Form 418 August 2026Common Stock · traded 18 August 2026 · filed 18 August 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 418 August 2026Common Stock · traded 18 August 2026 · filed 18 August 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 418 August 2026Non-Qualified Stock Option (Right to Buy) · traded 18 August 2026 · filed 18 August 2026
- exercised options over 3,500 shares of CytokineticsSEC Form 423 July 2026Common Stock · traded 21 July 2026 · filed 23 July 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 423 July 2026Common Stock · traded 21 July 2026 · filed 23 July 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 423 July 2026Non-Qualified Stock Option (Right to Buy) · traded 21 July 2026 · filed 23 July 2026
- exercised options over 3,500 shares of CytokineticsSEC Form 47 July 2026Common Stock · traded 7 July 2026 · filed 7 July 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 47 July 2026Common Stock · traded 7 July 2026 · filed 7 July 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 47 July 2026Non-Qualified Stock Option (Right to Buy) · traded 7 July 2026 · filed 7 July 2026
- was granted 22,862 shares of Rocket PharmaceuticalsSEC Form 46 July 2026Common Stock · traded 18 June 2026 · filed 6 July 2026
- was granted 64,860 shares of Rocket Pharmaceuticals (a derivative holding)SEC Form 46 July 2026Stock Option (Right to Buy) · traded 18 June 2026 · filed 6 July 2026
- exercised options over 3,500 shares of CytokineticsSEC Form 423 June 2026Common Stock · traded 23 June 2026 · filed 23 June 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 423 June 2026Common Stock · traded 23 June 2026 · filed 23 June 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 423 June 2026Non-Qualified Stock Option (Right to Buy) · traded 23 June 2026 · filed 23 June 2026
- exercised options over 3,500 shares of CytokineticsSEC Form 49 June 2026Common Stock · traded 9 June 2026 · filed 9 June 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 49 June 2026Common Stock · traded 9 June 2026 · filed 9 June 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 49 June 2026Non-Qualified Stock Option (Right to Buy) · traded 9 June 2026 · filed 9 June 2026
- exercised options over 3,500 shares of CytokineticsSEC Form 420 May 2026Common Stock · traded 19 May 2026 · filed 20 May 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 420 May 2026Common Stock · traded 19 May 2026 · filed 20 May 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 420 May 2026Non-Qualified Stock Option (Right to Buy) · traded 19 May 2026 · filed 20 May 2026
- exercised options over 3,500 shares of CytokineticsSEC Form 45 May 2026Common Stock · traded 5 May 2026 · filed 5 May 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 45 May 2026Common Stock · traded 5 May 2026 · filed 5 May 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 45 May 2026Non-Qualified Stock Option (Right to Buy) · traded 5 May 2026 · filed 5 May 2026
- exercised options over 3,500 shares of CytokineticsSEC Form 421 April 2026Common Stock · traded 21 April 2026 · filed 21 April 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 421 April 2026Common Stock · traded 21 April 2026 · filed 21 April 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 421 April 2026Non-Qualified Stock Option (Right to Buy) · traded 21 April 2026 · filed 21 April 2026
- exercised options over 3,500 shares of CytokineticsSEC Form 48 April 2026Common Stock · traded 7 April 2026 · filed 8 April 2026
- ▼ sold on the open market 3,500 shares of CytokineticsSEC Form 48 April 2026Common Stock · traded 7 April 2026 · filed 8 April 2026
- exercised options over 1,000 shares of CytokineticsSEC Form 48 April 2026Common Stock · traded 7 April 2026 · filed 8 April 2026
- ▼ sold on the open market 1,000 shares of CytokineticsSEC Form 48 April 2026Common Stock · traded 7 April 2026 · filed 8 April 2026
- exercised options over 3,500 shares of Cytokinetics (a derivative holding)SEC Form 48 April 2026Non-Qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 8 April 2026
- exercised options over 1,000 shares of Cytokinetics (a derivative holding)SEC Form 48 April 2026Non-Qualified Stock Option (Right to Buy) · traded 7 April 2026 · filed 8 April 2026
- ▼ sold on the open market 7,636 shares of CytokineticsSEC Form 418 March 2026Common Stock · traded 17 March 2026 · filed 18 March 2026
- ▼ sold on the open market 4,397 shares of CytokineticsSEC Form 418 March 2026Common Stock · traded 17 March 2026 · filed 18 March 2026
- ▼ sold on the open market 7,636 shares of CytokineticsSEC Form 418 March 2026Common Stock · traded 17 March 2026 · filed 18 March 2026
- ▼ sold on the open market 4,397 shares of CytokineticsSEC Form 418 March 2026Common Stock · traded 17 March 2026 · filed 18 March 2026
- was granted 27,306 shares of CytokineticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- was granted 1,665 shares of Cytokinetics (a derivative holding)SEC Form 417 March 2026Incentive Stock Option (Right to Buy) · traded 15 March 2026 · filed 17 March 2026
- was granted 39,527 shares of Cytokinetics (a derivative holding)SEC Form 417 March 2026Non-Qualified Stock Option (Right to Buy) · traded 15 March 2026 · filed 17 March 2026
- was granted 1,665 shares of Cytokinetics (a derivative holding)SEC Form 417 March 2026Incentive Stock Option (Right to Buy) · traded 15 March 2026 · filed 17 March 2026
- was granted 39,527 shares of Cytokinetics (a derivative holding)SEC Form 417 March 2026Non-Qualified Stock Option (Right to Buy) · traded 15 March 2026 · filed 17 March 2026
- was granted 27,306 shares of CytokineticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- ▼ sold on the open market 2,907 shares of CytokineticsSEC Form 410 March 2026Common Stock · traded 9 March 2026 · filed 10 March 2026
- ▼ sold on the open market 2,907 shares of CytokineticsSEC Form 410 March 2026Common Stock · traded 9 March 2026 · filed 10 March 2026
- was granted 2,000 shares of CytokineticsSEC Form 429 December 2025Common Stock · traded 22 December 2025 · filed 29 December 2025
- was granted 2,000 shares of CytokineticsSEC Form 429 December 2025Common Stock · traded 22 December 2025 · filed 29 December 2025
- had shares withheld for tax on 1,016 shares of CytokineticsSEC Form 429 December 2025Common Stock · traded 22 December 2025 · filed 29 December 2025
- exercised options over 2,200 shares of Cytokinetics (a derivative holding)SEC Form 416 December 2025Incentive Stock Option (Right to Buy) · traded 16 December 2025 · filed 16 December 2025
- exercised options over 2,200 shares of CytokineticsSEC Form 416 December 2025Common Stock · traded 16 December 2025 · filed 16 December 2025
- ▼ sold on the open market 2,200 shares of CytokineticsSEC Form 416 December 2025Common Stock · traded 16 December 2025 · filed 16 December 2025
- had shares withheld for tax on 2,058 shares of CytokineticsSEC Form 45 December 2025Common Stock · traded 3 December 2025 · filed 5 December 2025
- exercised options over 2,200 shares of Cytokinetics (a derivative holding)SEC Form 42 December 2025Incentive Stock Option (Right to Buy) · traded 2 December 2025 · filed 2 December 2025
- exercised options over 2,200 shares of CytokineticsSEC Form 42 December 2025Common Stock · traded 2 December 2025 · filed 2 December 2025
- ▼ sold on the open market 2,200 shares of CytokineticsSEC Form 42 December 2025Common Stock · traded 2 December 2025 · filed 2 December 2025
- exercised options over 2,200 shares of Cytokinetics (a derivative holding)SEC Form 418 November 2025Incentive Stock Option (Right to Buy) · traded 18 November 2025 · filed 18 November 2025
- exercised options over 2,200 shares of CytokineticsSEC Form 418 November 2025Common Stock · traded 18 November 2025 · filed 18 November 2025
- ▼ sold on the open market 2,200 shares of CytokineticsSEC Form 418 November 2025Common Stock · traded 18 November 2025 · filed 18 November 2025
- exercised options over 2,295 shares of Cytokinetics (a derivative holding)SEC Form 44 November 2025Incentive Stock Option (Right to Buy) · traded 4 November 2025 · filed 4 November 2025
- exercised options over 2,295 shares of CytokineticsSEC Form 44 November 2025Common Stock · traded 4 November 2025 · filed 4 November 2025
- ▼ sold on the open market 2,295 shares of CytokineticsSEC Form 44 November 2025Common Stock · traded 4 November 2025 · filed 4 November 2025
- exercised options over 2,105 shares of Cytokinetics (a derivative holding)SEC Form 421 October 2025Non-Qualified Stock Option (Right to Buy) · traded 21 October 2025 · filed 21 October 2025
- exercised options over 2,105 shares of CytokineticsSEC Form 421 October 2025Common Stock · traded 21 October 2025 · filed 21 October 2025
- ▼ sold on the open market 2,105 shares of CytokineticsSEC Form 421 October 2025Common Stock · traded 21 October 2025 · filed 21 October 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 47 October 2025Non-Qualified Stock Option (Right to Buy) · traded 7 October 2025 · filed 7 October 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 47 October 2025Common Stock · traded 7 October 2025 · filed 7 October 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 47 October 2025Common Stock · traded 7 October 2025 · filed 7 October 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 423 September 2025Non-Qualified Stock Option (Right to Buy) · traded 23 September 2025 · filed 23 September 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 423 September 2025Common Stock · traded 23 September 2025 · filed 23 September 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 423 September 2025Common Stock · traded 23 September 2025 · filed 23 September 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 410 September 2025Non-Qualified Stock Option (Right to Buy) · traded 9 September 2025 · filed 10 September 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 410 September 2025Common Stock · traded 9 September 2025 · filed 10 September 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 410 September 2025Common Stock · traded 9 September 2025 · filed 10 September 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 419 August 2025Non-Qualified Stock Option (Right to Buy) · traded 19 August 2025 · filed 19 August 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 419 August 2025Common Stock · traded 19 August 2025 · filed 19 August 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 419 August 2025Common Stock · traded 19 August 2025 · filed 19 August 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 45 August 2025Non-Qualified Stock Option (Right to Buy) · traded 5 August 2025 · filed 5 August 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 45 August 2025Common Stock · traded 5 August 2025 · filed 5 August 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 45 August 2025Common Stock · traded 5 August 2025 · filed 5 August 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 423 July 2025Non-Qualified Stock Option (Right to Buy) · traded 22 July 2025 · filed 23 July 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 423 July 2025Common Stock · traded 22 July 2025 · filed 23 July 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 423 July 2025Common Stock · traded 22 July 2025 · filed 23 July 2025
- was granted 30,000 shares of Rocket PharmaceuticalsSEC Form 418 July 2025Common Stock · traded 18 June 2025 · filed 18 July 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 48 July 2025Non-Qualified Stock Option (Right to Buy) · traded 8 July 2025 · filed 8 July 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 48 July 2025Common Stock · traded 8 July 2025 · filed 8 July 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 48 July 2025Common Stock · traded 8 July 2025 · filed 8 July 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 417 June 2025Non-Qualified Stock Option (Right to Buy) · traded 17 June 2025 · filed 17 June 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 417 June 2025Common Stock · traded 17 June 2025 · filed 17 June 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 417 June 2025Common Stock · traded 17 June 2025 · filed 17 June 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 43 June 2025Non-Qualified Stock Option (Right to Buy) · traded 3 June 2025 · filed 3 June 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 43 June 2025Common Stock · traded 3 June 2025 · filed 3 June 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 43 June 2025Common Stock · traded 3 June 2025 · filed 3 June 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 420 May 2025Non-Qualified Stock Option (Right to Buy) · traded 20 May 2025 · filed 20 May 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 420 May 2025Common Stock · traded 20 May 2025 · filed 20 May 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 420 May 2025Common Stock · traded 20 May 2025 · filed 20 May 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 46 May 2025Non-Qualified Stock Option (Right to Buy) · traded 6 May 2025 · filed 6 May 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 46 May 2025Common Stock · traded 6 May 2025 · filed 6 May 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 46 May 2025Common Stock · traded 6 May 2025 · filed 6 May 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 422 April 2025Non-Qualified Stock Option (Right to Buy) · traded 22 April 2025 · filed 22 April 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 422 April 2025Common Stock · traded 22 April 2025 · filed 22 April 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 422 April 2025Common Stock · traded 22 April 2025 · filed 22 April 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 48 April 2025Non-Qualified Stock Option (Right to Buy) · traded 8 April 2025 · filed 8 April 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 48 April 2025Common Stock · traded 8 April 2025 · filed 8 April 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 48 April 2025Common Stock · traded 8 April 2025 · filed 8 April 2025
- gave away 200 shares of CytokineticsSEC Form 419 March 2025Common Stock · traded 19 March 2025 · filed 19 March 2025
- was granted 2,293 shares of Cytokinetics (a derivative holding)SEC Form 418 March 2025Incentive Stock Option (Right to Buy) · traded 14 March 2025 · filed 18 March 2025
- was granted 58,465 shares of Cytokinetics (a derivative holding)SEC Form 418 March 2025Non-Qualified Stock Option (Right to Buy) · traded 14 March 2025 · filed 18 March 2025
- was granted 39,450 shares of CytokineticsSEC Form 418 March 2025Common Stock · traded 14 March 2025 · filed 18 March 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 418 March 2025Non-Qualified Stock Option (Right to Buy) · traded 18 March 2025 · filed 18 March 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 418 March 2025Common Stock · traded 18 March 2025 · filed 18 March 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 418 March 2025Common Stock · traded 18 March 2025 · filed 18 March 2025
- ▼ sold on the open market 4,389 shares of CytokineticsSEC Form 417 March 2025Common Stock · traded 17 March 2025 · filed 17 March 2025
- ▼ sold on the open market 8,228 shares of CytokineticsSEC Form 47 March 2025Common Stock · traded 6 March 2025 · filed 7 March 2025
- ▼ sold on the open market 2,449 shares of CytokineticsSEC Form 45 March 2025Common Stock · traded 3 March 2025 · filed 5 March 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 44 March 2025Non-Qualified Stock Option (Right to Buy) · traded 4 March 2025 · filed 4 March 2025
- exercised options over 2,000 shares of CytokineticsSEC Form 44 March 2025Common Stock · traded 4 March 2025 · filed 4 March 2025
- ▼ sold on the open market 2,000 shares of CytokineticsSEC Form 44 March 2025Common Stock · traded 4 March 2025 · filed 4 March 2025
- exercised options over 2,000 shares of Cytokinetics (a derivative holding)SEC Form 418 February 2025Non-Qualified Stock Option (Right to Buy) · traded 18 February 2025 · filed 18 February 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.